Gene · 116
NIH grants1,702
NIH grants whose papers are about the gene, through NIH's grant-paper links.
321 to 340 of 1,702
Download this page as JSON| Grant | Title | ADCYAP1 papers | Newest fiscal year |
|---|---|---|---|
| R01MH120262 | Dopamine function, inflammation and connectivity in PTSD | 2 | 2023 |
| F30AA028184 | The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking | 1 | 2023 |
| F32DK128969 | The impact of amygdala CGRP receptors on the development of persistent bladder pain. | 1 | 2023 |
| F32HL154558 | Rhythmogenic states of the respiratory network reveal differential opioid sensitivity | 1 | 2023 |
| F32MH125634 | Thalamolimbic circuit mechanisms for social threat processing | 1 | 2023 |
| I01CX001146 | Artificial Intelligence for the Management of Colorectal Neoplasia Using Combined-Modality Spectroscopy and Enhanced Imaging | 1 | 2023 |
| IK2CX001600 | Cognitive Training as a Novel Neuroscience-based Treatment for PTSD | 1 | 2023 |
| K07CA230182 | Epigenomic and transcriptomic markers of aggressive prostate cancer among African American men | 1 | 2023 |
| K12HD065987 | Mayo Clinic Building Interdisciplinary Research Careers in Women’s Health | 1 | 2023 |
| P01AT009965 | Boosting mind-body mechanisms and outcomes for chronic pain | 1 | 2023 |
| P01DK119130 | CNS Mechanisms Linking Exercise Training with Energy Balance and Metabolism | 1 | 2023 |
| P01HL114471 | Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma | 1 | 2023 |
| R00AG062787 | Genome-wide analysis of late-onset Alzheimer's disease using intergenerational, multi-trait, and cross-ancestry data | 1 | 2023 |
| R00HL145004 | Homeostatic Plasticity of the Respiratory Rhythm Generating Network | 1 | 2023 |
| R01AG060621 | Angiogenic Therapy: Novel Approaches to Enhance Bone Regeneration in Aging | 1 | 2023 |
| R01AG061190 | Preclinical assessment of GCPII inhibitors for cognition and tau pathology | 1 | 2023 |
| R01AG064244 | The Role of Synaptic Proteolysis in Alzheimer's Disease and Therapeutic Implications | 1 | 2023 |
| R01AI080581 | Immune signaling molecules involved in promoting the pathogenesis of eosinophilic esophagitis (EoE) | 1 | 2023 |
| R01AT005076 | Mechanisms of Novel Herbal Therapies for Sepsis. | 1 | 2023 |
| R01CA240472 | Targeting SNP BRMS1v2 A273V/A273V to reduce metastases in lung adenocarcinoma | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/116/grants?page=17